Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (2): 198-203.doi: 10.16098/j.issn.0529-1356.2018.02.010

• Cancer Biology • Previous Articles     Next Articles

Effect of 17-allylamino-17-demethoxygeldanamycin on cell cycle and apoptosis of JAR cells and the associated mechanisms

GU Miao BA Yi CUI Li-jun LIU Bai-yi AN Guo-qing LI Yu-hong XU Qian*   

  1. Department of Basic Medicine, Department of Biomedical Engineering, Chengde Medical College,Hebei Chengde 067000,China
  • Received:2017-07-03 Revised:2017-09-13 Online:2017-04-06 Published:2018-04-06
  • Contact: XU Qian E-mail:xuqian@163.com

Abstract:

Objective To explore the effects of 17-AAG on cell cycle and apoptosis of Choriocarcinoma cells JAR and to clarify the related mechanisms. Methods Choriocarcinoma cells JAR were cultured in vitro and incubated with 17-allylamino-17-demethoxygeldanamycin (17-AAG) at different concentrations for 24 hours. The apoptosis of JAR cells with different concentrations of 17-AAG was measured by TUNEL analysis and flow cytometry (Annexin V-FITC/PI). Cell cycle was analyzed by flow cytometry. Real-time PCR and Western blotting analysis were used for the detection of vascular endothelial growth factor(VEGF), cyclinD1,cyclinA1 and Caspase-3 mRNA levels and protein levels. Results 17-AAG had obvious inhibitory effect on JAR cell growth with concentration dependent. When the 17-AAG concentration increased, G2 phase retardation and obvious apoptosis were found in every groups. Real-time PCR revealed an decreased expression level of cyclinD1. Western blotting analysis revealed an decreased expression level of VEGF, cyclinD1 and an increased expression level of Caspase-3. Conclusion 17-AAG can inhibit the JAR cell proliferation activity, induce cell apoptosis, and may exert the effect by down-regulation of VEGF, cyclinD1 and up-regulation of Caspase-3.

Key words: 17-allylamino-17-demethoxygeldanamycin, Choriocarcinoma cells JAR, Vascular endothelial growth factor, Flow cytometry, Western blotting